Advertisement
Canada markets close in 23 minutes
  • S&P/TSX

    22,204.05
    +96.97 (+0.44%)
     
  • S&P 500

    5,260.40
    +11.91 (+0.23%)
     
  • DOW

    39,833.00
    +72.92 (+0.18%)
     
  • CAD/USD

    0.7387
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    83.07
    +1.72 (+2.11%)
     
  • Bitcoin CAD

    95,994.99
    +3,088.60 (+3.32%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,240.60
    +27.90 (+1.26%)
     
  • RUSSELL 2000

    2,123.72
    +9.37 (+0.44%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,394.98
    -4.54 (-0.03%)
     
  • VOLATILITY

    12.92
    +0.14 (+1.10%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6841
    +0.0036 (+0.53%)
     

7 Reasons Why Novavax Is a No-Brainer Pick Over Ocugen

7 Reasons Why Novavax Is a No-Brainer Pick Over Ocugen

Ocugen's share price has skyrocketed roughly seven times more than Novavax's has. Does that make Ocugen the smarter vaccine stock to buy right now? Here are seven reasons why Novavax stock is a no-brainer pick over Ocugen.